Rigel Pharma (RIGL) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $46.79 -0.91%
EPS Growth %: -34.9%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -34.9%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.06 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $5.18 million versus the consensus estimate of $2.67 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle reports earnings today: AI spending bet faces its toughest test yet
- Signet Jewelers (SIG) PT Raised to $136 at UBS on Strong Growth Prospects
- Vince Holding (VNCE) Tops Q2 EPS by 86c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
